The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A QTc study of cabazitaxel in patients with advanced solid tumors.
James Lloyd Wade
No relevant relationships to disclose
Shaker R. Dakhil
No relevant relationships to disclose
Ari David Baron
No relevant relationships to disclose
Sylvie Rottey
No relevant relationships to disclose
Frederick E. Millard
Research Funding - Sanofi
Gedske Daugaard
No relevant relationships to disclose
Jean-Pascal H. Machiels
Consultant or Advisory Role - Consultant
Honoraria - HONORARIA
William A. Conkright
No relevant relationships to disclose
Sunil Sharma
Research Funding - Sanofi
Patricia M.M.B. Soetekouw
Consultant or Advisory Role - Sanofi
Jeffrey Yachnin
Consultant or Advisory Role - Sanofi
Research Funding - Support for a vaccine study
Other Remuneration - Other
Lisa Sengeløv
Honoraria - Sanofi
Peter van Veldhuizen
No relevant relationships to disclose
Sanjiv S. Agarwala
Honoraria - Sanofi
TX Quyen Nguyen
Employment or Leadership Position - Sanofi
Mustapha Chadjaa
Employment or Leadership Position - Sanofi
Pierre Maison-Blanche
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi